What is Zacks Research’s Estimate for Chemours Q2 Earnings?

The Chemours Company (NYSE:CC) – Analysts at Zacks Research decreased their Q2 2026 earnings per share estimates for shares of Chemours in a research report issued on Wednesday, March 4th. Zacks Research analyst Team now forecasts that the specialty chemicals company will earn $0.60 per share for the quarter, down from their prior forecast of $0.69. The consensus estimate for Chemours’ current full-year earnings is $2.03 per share. Zacks Research also issued estimates for Chemours’ Q3 2026 earnings at $0.42 EPS, Q1 2027 earnings at $0.45 EPS, Q2 2027 earnings at $0.53 EPS and FY2028 earnings at $2.50 EPS.

Chemours (NYSE:CC) last announced its earnings results on Thursday, February 19th. The specialty chemicals company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.01 by $0.04. Chemours had a positive return on equity of 41.75% and a negative net margin of 6.41%.The company had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter in the prior year, the business earned $0.09 earnings per share. The business’s revenue for the quarter was down 2.2% on a year-over-year basis.

Several other research analysts have also recently weighed in on CC. BMO Capital Markets dropped their price objective on shares of Chemours from $20.00 to $19.00 and set an “outperform” rating for the company in a research report on Monday, February 23rd. Morgan Stanley raised their price target on Chemours from $15.00 to $17.00 and gave the company an “equal weight” rating in a report on Monday, February 23rd. UBS Group lifted their price objective on Chemours from $18.00 to $23.00 and gave the stock a “buy” rating in a research note on Monday, February 23rd. JPMorgan Chase & Co. increased their target price on Chemours from $13.00 to $17.00 and gave the company a “neutral” rating in a research note on Monday, February 23rd. Finally, Truist Financial boosted their target price on Chemours from $18.00 to $21.00 and gave the stock a “buy” rating in a research report on Wednesday, January 21st. Five equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Chemours has an average rating of “Hold” and a consensus price target of $18.40.

Chemours Stock Down 4.7%

Shares of NYSE:CC opened at $16.70 on Friday. The company has a quick ratio of 0.85, a current ratio of 1.78 and a debt-to-equity ratio of 16.33. The firm has a market cap of $2.51 billion, a P/E ratio of -6.73 and a beta of 1.60. Chemours has a 12 month low of $9.13 and a 12 month high of $21.85. The company’s 50-day moving average price is $16.29 and its two-hundred day moving average price is $14.73.

Hedge Funds Weigh In On Chemours

A number of large investors have recently made changes to their positions in CC. Atlas Capital Advisors Inc. acquired a new position in Chemours in the 4th quarter valued at $26,000. MTM Investment Management LLC acquired a new position in Chemours in the 2nd quarter valued at $27,000. Aster Capital Management DIFC Ltd bought a new stake in shares of Chemours during the 4th quarter valued at $28,000. Covestor Ltd grew its holdings in shares of Chemours by 204.7% during the 4th quarter. Covestor Ltd now owns 2,602 shares of the specialty chemicals company’s stock worth $31,000 after purchasing an additional 1,748 shares in the last quarter. Finally, Eurizon Capital SGR S.p.A. acquired a new stake in Chemours during the fourth quarter worth about $31,000. Institutional investors own 76.26% of the company’s stock.

Chemours Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Investors of record on Friday, February 27th will be issued a dividend of $0.0875 per share. The ex-dividend date of this dividend is Friday, February 27th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 2.1%. Chemours’s payout ratio is presently -14.11%.

About Chemours

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.